Enhancing Breast Cancer Screening in National Mammography Facilities: Insights and Challenges of Integrating Additional Ultrasound for Women with Dense Breasts — A Qualitative Analysis - Takeaways - MDSpire

Enhancing Breast Cancer Screening in National Mammography Facilities: Insights and Challenges of Integrating Additional Ultrasound for Women with Dense Breasts — A Qualitative Analysis

  • By

  • Susanne A. Elsner

  • Eva Haußmann

  • Paula Grieger

  • Moritz Hadwiger

  • Andrea Rieck

  • Astrid Hacker

  • Sylvia Heywang-Köbrunner

  • Alexander Katalinic

  • October 31, 2025

  • 0 min

Share

  • 1

    The German breast cancer screening program invites women aged 50–75 to participate every two years, aiming to reduce breast cancer mortality.

  • 2

    Mammography sensitivity is lower in women with dense breast tissue, which can mask cancers, leading to delayed diagnoses and worse prognoses.

  • 3

    Supplemental breast ultrasound can enhance diagnostic accuracy for women with dense breasts, showing an additional cancer detection rate of 2–3 cases per 1,000 exams.

  • 4

    There is currently no consensus on supplemental screening for women with dense breasts in Germany, with concerns about false positives and overdiagnosis.

  • 5

    The DIMASOS 2 study explored the feasibility of integrating ultrasound into mammography screening for women with dense breasts through qualitative interviews.

Original Source(s)

Enhancing Breast Cancer Screening in National Mammography Facilities: Insights and Challenges of Integrating Additional Ultrasound for Women with Dense Breasts — A Qualitative Analysis

  • by Susanne A. Elsner, Eva Haußmann, Paula Grieger, Moritz Hadwiger, Andrea Rieck, Astrid Hacker, Sylvia Heywang-Köbrunner, Alexander Katalinic

  • October 31, 2025

Related Content

Longitudinal predictor analysis of pain in breast cancer survivors on aromatase inhibitors—the PAC-WOMAN trial

Effect of lidocaine on acute pain after modified radical mastectomy: a secondary analysis of a randomized trial

Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer